Literature DB >> 6726960

Testis tumors: the clinical significance of the tumor-contaminated scrotum.

M A Boileau, W D Steers.   

Abstract

Between 1977 and 1979 we evaluated 224 patients with testicular cancer. Of these patients 32 had undergone inadequate primary procedures, such as transscrotal orchiectomy, transcrotal exploration, biopsy or aspiration. These 32 patients were compared to a cohort population who had undergone radical inguinal orchiectomy. Differences in management, nodal metastases, local recurrences, intervals free of disease and survival by stage of disease were determined. Patients with seminoma and a contaminated scrotum received radiation therapy to the involved hemiscrotum . Partial scrotectomy without ilioinguinal node dissection was performed on most patients with nonseminomatous disease. An inguinal node metastasis developed before radiation therapy in a patient with seminoma. There were no local recurrences. No statistically significant difference in either intervals free of disease or survival between contaminated and cohort populations was found. We conclude that with prompt adequate management there is no adverse effect on prognosis due solely to scrotal tumor contamination, contrary to what has been implied in the literature.

Entities:  

Mesh:

Year:  1984        PMID: 6726960     DOI: 10.1016/s0022-5347(17)49460-2

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  3 in total

1.  Factors that impact the outcomes in testicular germ cell tumors in low-middle-income countries.

Authors:  S V Saju; Venkatraman Radhakrishnan; Trivadi S Ganesan; Manikandan Dhanushkodi; Anand Raja; Ganesarajah Selvaluxmy; Tenali Gnana Sagar
Journal:  Med Oncol       Date:  2019-02-06       Impact factor: 3.064

Review 2.  Biomarkers of disease recurrence in stage I testicular germ cell tumours.

Authors:  Peter Lesko; Michal Chovanec; Michal Mego
Journal:  Nat Rev Urol       Date:  2022-08-26       Impact factor: 16.430

3.  Scrotal Involvement with Testicular Nonseminomatous Germ Cell Tumour.

Authors:  C G O'Leary; J A Allen; F O'Brien; A Tuthill; D G Power
Journal:  Case Rep Oncol Med       Date:  2016-10-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.